ARCT
Arcturus Therapeutics Holdings Inc
14.70$
-8.4%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 0.8% | 1.4% | 3.2% | 107.8% | 156.0% | 586.5% | 1,405.9% | 69.5% | 1.9% | 2.6% | 4.5% | |
| – | 99.2% | 98.6% | 96.8% | -7.8% | 100.0% | -486.5% | 100.0% | 100.0% | 100.0% | 100.0% | 95.5% | |
| – | 219.3% | 90.2% | 122.5% | 107.8% | 161.8% | 606.4% | 1,405.9% | 71.8% | 121.8% | 141.0% | 166.9% | |
| – | 81.3% | 26.3% | 58.3% | 130.7% | 60.9% | 243.4% | 335.4% | 22.4% | 33.5% | 38.2% | 68.5% | |
| – | 320.9% | 123.5% | 180.7% | 238.5% | 222.7% | 263.3% | 1,741.3% | 94.1% | 149.6% | 169.1% | 207.0% | |
| – | -320.9% | -123.5% | -80.7% | -138.5% | -122.7% | -749.8% | -1,641.3% | 5.9% | -49.6% | -69.1% | -111.5% | |
| – | 4.1% | 1.4% | 1.2% | 1.2% | 4.1% | 8.7% | 21.6% | 1.5% | 0.5% | 0.0% | 0.0% | |
| – | -316.0% | -120.4% | -83.9% | -138.3% | -125.0% | -756.3% | -1,648.0% | 5.2% | -17.7% | -58.5% | -97.9% | |
| – | 0.8% | 0.4% | 0.0% | 1.3% | -1.3% | -8.2% | 25.8% | 0.6% | 1.2% | 0.0% | -112.9% | |
| – | -316.9% | -120.7% | -83.9% | -138.3% | -125.0% | -756.3% | -1,648.0% | 4.5% | -18.8% | -58.5% | -97.9% | |
| – | -28.0% | -4.6% | -79.6% | -131.5% | -117.6% | -740.6% | -1,616.7% | 7.4% | -15.3% | -55.9% | -93.4% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.